Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension

European Respiratory Journal

Volumn 43, Issue 3, 2014, Pages 915-917

  Cracowski, Jean Luc ^a,b   Chabot, Francois ^c   Labarère, Jose ^a,b   Faure, Patrice ^a,b   Degano, Bruno ^d   Schwebel, Carole ^a   Chaouat, Ari ^c   Reynaud Gaubert, Martine ^e   Cracowski, Claire ^a   Sitbon, Olivier ^f,g,h   Yaici, Azzedine ^f,g,h   Simonneau, Gerald ^f,g,h   Humbert, Marc ^f,g,h  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b UNIV GRENOBLE ALPES   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d UNIVERSITY HOSPITAL OF BESANÇON   (France)

^e University Hospital   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^h CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; COHORT ANALYSIS; DEATH; FEMALE; FRANCE; HUMAN; INFLAMMATION; LETTER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION;

ADULT; AGED; CYTOKINES; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INFLAMMATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME;

EID: 84895529835     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00151313     Document Type: Letter

References (12)

1. Voelkel NF, Gomez-Arroyo J, Abbate A, et al. Pathobiology of pulmonary arterial hypertension and right ventricular failure. Eur Respir J 2012; 40: 1555-1565.
2. Price LC, Wort SJ, Perros F, et al. Inflammation in pulmonary arterial hypertension. Chest 2012; 141: 210-221.
3. Cracowski JL, Leuchte HH. The potential of biomarkers in pulmonary arterial hypertension. Am J Cardiol 2012; 110: Suppl. 6, 32S-38S.
4. Huertas A, Tu L, Gambaryan N, et al. Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension. Eur Respir J 2012; 40: 895-904.
5. Zhou X, Fragala MS, McElhaney JE, et al. Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research. Curr Opin Clin Nutr Metab Care 2010; 13: 541-547.
6. Cracowski JL. Towards prognostic biomarkers in pulmonary arterial hypertension. Eur Respir J 2012; 39: 799-801.
7. Soon E, Holmes AM, Treacy CM, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 2010; 122: 920-927.
8. Cracowski JL, Degano B, Chabot F, et al. Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension. Chest 2012; 142: 869-876.
9. Rhodes CJ, Wharton J, Howard LS, et al. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart 2011; 97: 1054-1060.
10. Price LC, Montani D, Tcherakian C, et al. Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats. Eur Respir J 2011; 37: 813-822.
11. Keustermans GCE, Hoeks SBE, Meerding JM, et al. Cytokine assays: an assessment of the preparation and treatment of blood and tissue samples. Methods 2013; 61: 10-17.
12. Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010; 122: 156-163.